Virios Therapeutics (VIRI) Tops Q1 EPS by 8c
Tweet
Share
E-mailGet Alerts VIRI Hot Sheet
Join SI Premium – FREE
Virios Therapeutics (NASDAQ: VIRI) reported Q1 EPS of ($0.08), $0.08 better than the analyst estimate of ($0.16).
For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chewy (CHWY) Reports In-Line Q2 EPS, Offers Guidance
- J.Jill (JILL) Tops Q2 EPS by 67c, Beats on Revenue; Offers Guidance
- BofA Securities Downgrades Patria Investments (PAX) to Underperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
